Clinical trials
HPV clinical trials
Below are recruiting hpv clinical trials, each written for real people, not researchers. We’re tracking 257 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05365048Recruiting
Promoting HPV vaccine visits in kids ages 9–12
This study looks at whether getting a provider recommendation helps more parents bring children ages 9–12 in for HPV vaccination. It may help increase vaccination uptake in pediatric clinics.
Pasadena, CaliforniaAges 21–70 - NCT04704648Recruiting
Surgery for a one-eye surface tumor in people with HIV
This study looks at whether removing a suspected pre-cancer/cancer growth on the surface of the eye can be done safely in people living with HIV. It is a feasibility (safety and practical) study, helping doctors refine the best surgical approach and follow-up.
KampalaAges 18 years+ - NCT05566106Recruiting
Study follow-up for high-risk HPV in people with gynecologic history
This study looks at follow-up care for anal (rear passage) HPV risk in adults who previously had high-risk HPV–related gynecologic changes. It aims to better track disease that may be related to HPV and possibly help guide future monitoring.
ParisAges 18 years+ - NCT07104240Recruiting
Improving HPV vaccination for preteens ages 9-12
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
Atlanta, GeorgiaAges 9 years+ - NCT04988074RecruitingPhase 2
Test cemiplimab for HPV-positive throat cancer using tumor biomarkers
This Phase 2 trial studies whether cemiplimab (with or without chemotherapy first) can improve treatment for HPV-positive oropharynx throat cancer. It also uses lab “biomarkers” to help guide which treatment you get next.
Baltimore, MarylandAges 18 years+ - NCT04232917RecruitingPhase 4
Testing a treatment to help clear genital high-risk HPV
This trial studies 2LPAPI® to see if it helps the body clear high-risk HPV infections in the cervix. It may be an option if you have a current HPV infection with mild/early abnormal cervical findings and can complete follow-up for about a year.
BrusselsAges 25–45 - NCT07668271RecruitingPhase 4
HPV 9-valent vaccine lot consistency trial for women
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
Zhangping, FujianAges 18–30 - NCT06109870Recruiting
Increasing cervical cancer screening in Texas communities
This study tests a new community-based program to help women who are overdue for cervical cancer screening get easier access to testing. It’s designed for women in underserved areas of Texas who haven’t had a recent Pap or HPV test.
Austin, TexasAges 18 years+ - NCT06206564RecruitingPhase 2
Artesunate ointment for anal precancer in HIV-negative adults
This trial tests an artesunate ointment to treat high-grade anal precancer (HSIL) in people who do not have HIV. The goal is to see if the ointment can clear the abnormal cells caused by HPV.
Chicago, IllinoisAges 18 years+ - NCT07060261Recruiting
Pre-op MRI for HPV+ tonsil cancer surgery
This trial is looking at whether an MRI before surgery can help improve outcomes for people with HPV-positive tonsil cancer who are undergoing robotic surgery (TORS). The results may help doctors better plan surgery to remove all cancer.
Cleveland, OhioAges 18 years+ - NCT07047989RecruitingPhase 1
NWRD09 for HPV-16 related cervical high-grade changes
This trial tests a new drug called NWRD09 for women with high-grade cervical cell changes (CIN 2/3) caused by HPV type 16. The goal is to see if the drug can help clear these abnormal cells without needing surgery.
BeijingAges 18–65 - NCT07538050Recruiting
Testing a new, affordable HPV screening method
This study tests ScreenFire, a new low-cost test for HPV (a virus linked to cervical cancer) that you can do yourself at home. Researchers want to see if it works as well as standard tests and costs less.
San Salvador, OrienteAges 30–59 - NCT05985681RecruitingPhase 1
Testing an HPV vaccine to prevent cancer
This trial tests a new vaccine (RG1-VLP) to see if it can prevent HPV-related cancers. It is for women aged 18 to 60 who have not had an HPV vaccine before.
Birmingham, AlabamaAges 18–60 - NCT07171658Recruiting
Cervical cancer screening for women getting breast cancer letters
This trial tests if inviting women for cervical cancer screening along with their breast cancer screening letters helps more people get tested. You might be eligible if you haven't had a cervical cancer screening in the last three years.
Geneva, Canton of GenevaAges 50–74 - NCT05600842Recruiting
Lower-dose radiation for HPV-positive throat cancer
This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.
Orange, CaliforniaAges 18 years+ - NCT06535139Recruiting
HPV Vaccine Study for Rural Kids 8 to 12
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
Gainesville, FloridaAges 8–99 - NCT06007092RecruitingPhase 1/Phase 2
HPV vaccine trial for oropharyngeal cancer patients
This trial tests a therapeutic vaccine for people with HPV16-positive oropharyngeal cancer who have finished curative treatment and are free of disease. The vaccine aims to help the immune system prevent the cancer from coming back.
VillejuifAges 18 years+ - NCT06808776Recruiting
Stories to prevent HPV cancers
This trial tests if sharing stories can help parents decide to get their child the HPV vaccine. It is for parents of children ages 9 to 12 who have not yet started the HPV shot series.
Hershey, PennsylvaniaAges 18 years+ - NCT06610773RecruitingPhase 1/Phase 2
Stem cell treatment for high-risk HPV infection
This trial tests whether umbilical cord stem cells can help clear a persistent high-risk HPV infection. It is for women aged 25 to 60 who have had HPV for a while and have not been treated with other HPV drugs recently.
Shanghai, Shanghai MunicipalityAges 25–60 - NCT06005324RecruitingPhase 1
Personalized treatment for advanced head and neck cancer
This trial tests a custom treatment plan for people with advanced head and neck cancer that is not caused by HPV. It combines radiation and chemotherapy with a targeted drug called cetuximab, adjusted based on your tumor's characteristics.
Chicago, IllinoisAges 18 years+ - NCT06147388Recruiting
Can cervical precancer heal on its own?
This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.
PragueAges 18–40 - NCT07725328Enrolling by invitation
Mobile health program for cancer screening and healthy habits
This trial tests if a mobile app or text messages can help women in Singapore stay on top of cancer screening and adopt healthier habits. It may be a good fit if you're a woman aged 50 to 69 who lives in Singapore.
SingaporeAges 50–69 - NCT07156227RecruitingPhase 1
Testing camonsertib with radiation for returning head and neck cancer
This study tests whether adding the drug camonsertib to radiation therapy can help people whose head and neck cancer has come back in a spot that was already treated with radiation. Camonsertib is an experimental drug that may help radiation work better.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06810739Recruiting
Women's Screening and Self-Testing Program (PROMETA)
This study tests a self-screening program for cervical cancer among women who are already receiving HIV care. It aims to make screening easier and more accessible.
MaputoAges 25–49
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hpv?
- Yes. Clin2 currently lists 257 recruiting hpv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hpv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hpv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.